MSH|^~\&|LAB|RMH|||202002120910||ORU^R01|4166200|D|2.3|||AL|NE
PID|1||RM00003588|RM3174|LABTEST^NLAN^||19751015|F||||||||||RM000111/19|9875031474
OBR|1|39279^LAB|00029633^1202:C00007R^LAB^120220:C7^39279|499.0048^QCOWCARM1^QC ONE WORLD CARDIAC MARKERS 1^^^||202002120908|202002120700|||||||202002120907||||||||||LAB|F||||
OBX|1|ST|500.6900^CRPH^C-Reactive Protein High Sens^^30522-7^30522-7|1|5.2^^Y|mg/L|<7.5|N||A^S|F|||202002120910
NTE|1||This high sensitivity CRP method is sensitive to 0.3 mg/L
NTE|2||and is suitable for coronary artery risk assessment:
NTE|3||                         Less than 1.0 mg/L  low risk;
NTE|4||                         1.0 - 3.0 mg/L  intermediate risk;
NTE|5||                         Greater than 3.0 mg/L  high risk.
NTE|6||Values greater than 7.5 mg/L are significant for active
NTE|7||inflammation or infection and require follow up as
NTE|8||clinically needed. For consultation on specific patient
NTE|9||cases call your site Medical Biochemist. Interpretation
NTE|10||should be based on full history and other risk assessment
NTE|11||factors.

